Discovery of BRD9 Molecular Glue Degraders That Spare Cardiomyocytes.
Journal of the American Chemical Society. 2025 October. doi: 10.1021/jacs.5c09857.
Structural ubiquitin contributes to K48 linkage specificity of the HECT ligase Tom1.
Cell Reports. 2025 May. doi: 10.1016/j.celrep.2025.115688.
Decoding Protein–Peptide Interactions Using a Large, Target-Agnostic Yeast Surface Display Library.
ACS Chemical Biology. 2025 September. doi: 10.1021/acschembio.5c00265.
Structural basis of VCP-VCPIP1-p47 ternary complex in Golgi maintenance.
Nature Communications. 2025 August. doi: 10.1038/s41467-025-63161-3.
Development of FBXO22 Degraders and the Recruitment Ligand 2-Pyridinecarboxyaldehyde (2-PCA).
Journal of the American Chemical Society. 2025 December. doi: 10.1021/jacs.5c14141.
Expanding the druggable zinc-finger proteome defines properties of drug-induced degradation.
Mol Cell.
2025 Aug 21;85(16):3184-3201.e14. doi: 10.1016/j.molcel.2025.07.019. PubMed PMID:
40845806; PubMed Central PMCID:
PMC12458990.
Development of Degraders and 2-pyridinecarboxyaldehyde (2-PCA) as a recruitment Ligand for FBXO22.
bioRxiv.
2025 Aug 20;. doi: 10.1101/2025.08.19.671158. PubMed PMID:
40894587; PubMed Central PMCID:
PMC12393450.
Rational Design of CDK12/13 and BRD4 Molecular Glue Degraders.
Angew Chem Int Ed Engl.
2025 Sep 15;64(38):e202508427. doi: 10.1002/anie.202508427. Epub 2025 Aug 7. PubMed PMID:
40626960; PubMed Central PMCID:
PMC12831537.
Discovery of PXR Antagonist MI891 and PXR Degrader MI1013 and Their Roles in Hepatic Gene Regulation.
J Med Chem.
2025 Jul 24;68(14):14271-14299. doi: 10.1021/acs.jmedchem.4c03134. Epub 2025 Jul 12. PubMed PMID:
40650588; PubMed Central PMCID:
PMC12305494.
Development and Characterization of the First Selective Class IIb Histone Deacetylase Degraders.
J Med Chem.
2025 Jul 10;68(13):13793-13821. doi: 10.1021/acs.jmedchem.5c00674. Epub 2025 Jun 18. PubMed PMID:
40532131; PubMed Central PMCID:
PMC12245577.
Niclosamide: CRL4(AMBRA1) mediated degradation of cyclin D1 following mitochondrial membrane depolarization.
RSC Med Chem.
2025 Jul 16;16(7):3049-3057. doi: 10.1039/d5md00054h. eCollection 2025 Jul 16. PubMed PMID:
40337304; PubMed Central PMCID:
PMC12054360.
Acute BRCAness induction and AR pathway blockage through CDK12/7/9 degradation enhances PARP inhibitor sensitivity in prostate cancer.
Sci Adv.
2025 Apr 25;11(17):eadu0847. doi: 10.1126/sciadv.adu0847. Epub 2025 Apr 23. PubMed PMID:
40267193; PubMed Central PMCID:
PMC12017310.
Rational Design and Optimization of a Potent IDO1 Proteolysis Targeting Chimera (PROTAC).
J Med Chem.
2025 Feb 27;68(4):4961-4987. doi: 10.1021/acs.jmedchem.5c00026. Epub 2025 Feb 13. PubMed PMID:
39946350; PubMed Central PMCID:
PMC11874035.
Development of Potent and Selective CK1α Molecular Glue Degraders.
J Med Chem.
2025 Feb 13;68(3):3180-3196. doi: 10.1021/acs.jmedchem.4c02415. Epub 2025 Jan 28. PubMed PMID:
39873536; PubMed Central PMCID:
PMC12861308.
Development of the First-in-Class FEM1B-Recruiting Histone Deacetylase Degraders.
J Med Chem.
2025 Jan 23;68(2):1824-1843. doi: 10.1021/acs.jmedchem.4c02569. Epub 2025 Jan 13. PubMed PMID:
39804678; PubMed Central PMCID:
PMC11780399.
Development of sulfonyl fluoride chemical probes to advance the discovery of cereblon modulators.
RSC Medicinal Chemistry. 2024. doi: 10.1039/D3MD00652B.
Broad-spectrum activity against mosquito-borne flaviviruses achieved by a targeted protein degradation mechanism.
Nature Communications. 2024 June. doi: 10.1038/s41467-024-49161-9.
Targeted protein degradation: from mechanisms to clinic.
Nature Reviews Molecular Cell Biology. 2024 September. doi: 10.1038/s41580-024-00729-9.
Ubiquitin-specific proximity labeling for the identification of E3 ligase substrates.
Nature Chemical Biology. 2024 September. doi: 10.1038/s41589-024-01590-9.
Ternary complex formation of VCP, VCPIP1 and p47 facilitates Golgi reassembly. 2024 October. DOI: 10.1101/2024.10.01.616120.
Discovery of CRBN-Dependent WEE1 Molecular Glue Degraders from a Multicomponent Combinatorial Library.
J Am Chem Soc.
2024 Nov 20;146(46):31433-31443. doi: 10.1021/jacs.4c06127. Epub 2024 Nov 5. PubMed PMID:
39499896; PubMed Central PMCID:
PMC11800961.
Unveiling the hidden interactome of CRBN molecular glues with chemoproteomics.
bioRxiv.
2024 Oct 4;. doi: 10.1101/2024.09.11.612438. PubMed PMID:
39314457; PubMed Central PMCID:
PMC11419069.
Discovery of electrophilic degraders that exploit S(N)Ar chemistry.
bioRxiv.
2024 Sep 27;. doi: 10.1101/2024.09.25.615094. PubMed PMID:
39386645; PubMed Central PMCID:
PMC11463635.
Exploration of the tunability of BRD4 degradation by DCAF16 trans-labelling covalent glues.
Eur J Med Chem.
2024 Dec 5;279:116904. doi: 10.1016/j.ejmech.2024.116904. Epub 2024 Sep 24. PubMed PMID:
39341093; PubMed Central PMCID:
PMC11960843.
Template-assisted covalent modification underlies activity of covalent molecular glues.
Nat Chem Biol.
2024 Dec;20(12):1640-1649. doi: 10.1038/s41589-024-01668-4. Epub 2024 Jul 29. PubMed PMID:
39075252; PubMed Central PMCID:
PMC11582070.
Discovery of bivalent small molecule degraders of cyclin-dependent kinase 7 (CDK7).
Eur J Med Chem.
2024 Oct 5;276:116613. doi: 10.1016/j.ejmech.2024.116613. Epub 2024 Jun 27. PubMed PMID:
39004018; PubMed Central PMCID:
PMC11316633.
Author Correction: Targeting DCAF5 suppresses SMARCB1-mutant cancer by stabilizing SWI/SNF.
Nature.
2024 May;629(8012):E12. doi: 10.1038/s41586-024-07402-3. PubMed PMID:
38684813.
Targeting DCAF5 suppresses SMARCB1-mutant cancer by stabilizing SWI/SNF.
Nature.
2024 Apr;628(8007):442-449. doi: 10.1038/s41586-024-07250-1. Epub 2024 Mar 27. PubMed PMID:
38538798; PubMed Central PMCID:
PMC11184678.
Continuous evolution of compact protein degradation tags regulated by selective molecular glues.
Science.
2024 Mar 15;383(6688):eadk4422. doi: 10.1126/science.adk4422. Epub 2024 Mar 15. PubMed PMID:
38484051; PubMed Central PMCID:
PMC11203266.
Multiomic profiling of breast cancer cells uncovers stress MAPK-associated sensitivity to AKT degradation.
Sci Signal.
2024 Feb 27;17(825):eadf2670. doi: 10.1126/scisignal.adf2670. Epub 2024 Feb 27. PubMed PMID:
38412255; PubMed Central PMCID:
PMC10949348.
HDAC6/aggresome processing pathway importance for inflammasome formation is context-dependent.
J Biol Chem.
2024 Feb;300(2):105638. doi: 10.1016/j.jbc.2024.105638. Epub 2024 Jan 8. PubMed PMID:
38199570; PubMed Central PMCID:
PMC10850954.
Structures of BIRC6-client complexes provide a mechanism of SMAC-mediated release of caspases.
Science. 2023 March. doi: 10.1126/science.ade5750.
E3-Specific Degrader Discovery by Dynamic Tracing of Substrate Receptor Abundance.
Journal of the American Chemical Society. 2023 January. doi: 10.1021/jacs.2c10784.
HDAC6/aggresome processing pathway importance for inflammasome formation is context dependent. 2023 August. DOI: 10.1101/2023.08.15.553363.
Development of a covalent cereblon-based PROTAC employing a fluorosulfate warhead.
RSC Chemical Biology. 2023. doi: 10.1039/D3CB00103B.
Covalent Stapling of the Cereblon Sensor Loop Histidine Using Sulfur-Heterocycle Exchange.
ACS Medicinal Chemistry Letters. 2023 November. doi: 10.1021/acsmedchemlett.3c00371.
Proteolysis-targeting chimeras with reduced off-targets.
Nat Chem.
2024 Feb;16(2):218-228. doi: 10.1038/s41557-023-01379-8. Epub 2023 Dec 18. PubMed PMID:
38110475; PubMed Central PMCID:
PMC10913580.
Proteomics-Based Discovery of First-in-Class Chemical Probes for Programmed Cell Death Protein 2 (PDCD2).
Angew Chem Int Ed Engl.
2023 Oct 23;62(43):e202308292. doi: 10.1002/anie.202308292. Epub 2023 Sep 15. PubMed PMID:
37658265; PubMed Central PMCID:
PMC10592021.
Design principles for cyclin K molecular glue degraders.
Nat Chem Biol.
2024 Jan;20(1):93-102. doi: 10.1038/s41589-023-01409-z. Epub 2023 Sep 7. PubMed PMID:
37679459; PubMed Central PMCID:
PMC10746543.
Development of a highly potent and selective degrader of LRRK2.
Bioorg Med Chem Lett.
2023 Oct 1;94:129449. doi: 10.1016/j.bmcl.2023.129449. Epub 2023 Aug 15. PubMed PMID:
37591317; PubMed Central PMCID:
PMC11837620.
HDAC3 and HDAC8 PROTAC dual degrader reveals roles of histone acetylation in gene regulation.
Cell Chem Biol.
2023 Nov 16;30(11):1421-1435.e12. doi: 10.1016/j.chembiol.2023.07.010. Epub 2023 Aug 11. PubMed PMID:
37572669; PubMed Central PMCID:
PMC10802846.
Targeted kinase degradation via the KLHDC2 ubiquitin E3 ligase.
Cell Chem Biol.
2023 Nov 16;30(11):1414-1420.e5. doi: 10.1016/j.chembiol.2023.07.008. Epub 2023 Aug 10. PubMed PMID:
37567174; PubMed Central PMCID:
PMC10839117.
Development and Characterization of Selective FAK Inhibitors and PROTACs with In Vivo Activity.
Chembiochem.
2023 Oct 4;24(19):e202300141. doi: 10.1002/cbic.202300141. Epub 2023 Jul 24. PubMed PMID:
37088717; PubMed Central PMCID:
PMC10590827.
HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways.
Cell Rep.
2023 May 30;42(5):112496. doi: 10.1016/j.celrep.2023.112496. Epub 2023 May 9. PubMed PMID:
37167062; PubMed Central PMCID:
PMC10279472.
Catalytic Degraders Effectively Address Kinase Site Mutations in EML4-ALK Oncogenic Fusions.
J Med Chem.
2023 Apr 27;66(8):5524-5535. doi: 10.1021/acs.jmedchem.2c01864. Epub 2023 Apr 10. PubMed PMID:
37036171; PubMed Central PMCID:
PMC11827123.
ITK degradation to block T cell receptor signaling and overcome therapeutic resistance in T cell lymphomas.
Cell Chem Biol.
2023 Apr 20;30(4):383-393.e6. doi: 10.1016/j.chembiol.2023.03.007. Epub 2023 Apr 3. PubMed PMID:
37015223; PubMed Central PMCID:
PMC10151063.
Targeting the Dark Lipid Kinase PIP4K2C with a Potent and Selective Binder and Degrader.
Angew Chem Int Ed Engl.
2023 Apr 24;62(18):e202302364. doi: 10.1002/anie.202302364. Epub 2023 Mar 27. PubMed PMID:
36898968; PubMed Central PMCID:
PMC10150580.
MEN1 mutations mediate clinical resistance to menin inhibition.
Nature.
2023 Mar;615(7954):913-919. doi: 10.1038/s41586-023-05755-9. Epub 2023 Mar 15. PubMed PMID:
36922589; PubMed Central PMCID:
PMC10157896.
Diagnostic TR-FRET assays for detection of antibodies in patient samples.
Cell Rep Methods.
2023 Mar 27;3(3):100421. doi: 10.1016/j.crmeth.2023.100421. eCollection 2023 Mar 27. PubMed PMID:
37056371; PubMed Central PMCID:
PMC10088089.
Structures of BIRC6-client complexes provide a mechanism of SMAC-mediated release of caspases.
Science.
2023 Mar 17;379(6637):1105-1111. doi: 10.1126/science.ade5750. Epub 2023 Feb 9. PubMed PMID:
36758104.
What would you like to do?